Naltrexone: Demystifying Myths | May 16, 2023
Date of Presentation: May 16, 2023
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #addiction #alcohol #aud #naltrexone #opioid #OUD
In this presentation, CAPT Ted Hall, PharmD, provides a comprehensive overview of oral and injectable naltrexone. CAPT Hall discusses the pharmacology, applications of use for chemical and behavioral addictions, examples of naltrexone induction protocols for opioid use disorder, and demonstrates anecdotal data related to mitigating opioid cravings and supporting abstinence.
Recording:
Presented by:
CAPT Ted Hall, PharmD, BCPP
CAPT Ted Hall, PharmD, BCPP, graduated from the Nesbitt School of Pharmacy at Wilkes University with a Doctor of Pharmacy in 2002. He has served the Ho-Chunk Nation Health Department since September 2002 as a staff pharmacist and advanced to Chief Pharmacist in 2009. In 2019, he transferred billets to an Advanced Practice Pharmacist II. CAPT Hall is privileged by the Ho-Chunk Nation Medical Staff as a clinical psychiatric pharmacist non-physician medical provider under a Clinical Pharmacist Collaborative Practice Agreement for Psychiatric and Substance Abuse Disorders with diagnostic and prescriptive authority.
Ted served as the Principle IHS Lead for the US White House Office/Office of National Drug Control Policy National Heroin Task Force in 2015. He also served on the Substance Abuse and Mental Health Services Administration (SAMHSA) Technical Expert Panel to develop an Evidence-Based Guidebook on Treatment of Stimulant Use in 2019. He currently is serving on the Office of the White House/Office of National Drug Control Policy Coordinating Committee, Eliminating Barriers to Treatment Sub-Committee.
Resources Provided:
- Clinical Opiate Withdrawal Scale (COWS)
- Primary Care Evidence Based Addiction Withdrawal Supportive Care Treatment Protocol (Ho-Chunk Nation)
- Recommendations to the IHS on AI/AN Pregnant Women and Women of Childbearing Age with Opioid Use Disorder (American College of Obstetricians and Gynecologists)
- Physicochemical Stability of Compounded Naltrexone Hydrochloride Solutions in PCCA Base, SuspendIt
- Naltrexone: Demystifying Myths (Presentation Slides)
- Reduced cigarette smoking during injectable extended-release naltrexone treatment for opioid use disorder (American Journal of Drug and Alcohol Abuse)
- The use of naltrexone in pathological and problem gambling: A UK case series (Journal of Behavioral Addictions)
- The influence of opioid blockage on the sexual response cycle: A randomized placebo-controlled experiment with relevance for the treatment of Compulsive Sexual Behavior Disorder (CSBD) (Psychoneuroendocrinology)
Date added: May 14, 2023